Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant.” Since then antibiotics have proved one of the most effective interventions in human medicine. Sadly, the overuse and misuse of this precious resource have brought us to a global crisis of antimicrobial resistance (AMR). To address this crisis nearly seven decades after Fleming’s lecture the first UN general assembly meeting on drug resistance bacteria was convened in September 2017.
more
PLoS ONE 11(1): e0144662. doi:10.1371/journal.pone.0144662
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
La inmunización es un servicio esencial de salud que protege a las personas susceptibles de contraer enfermedades prevenibles mediante vacunación.2 L a vacunación oportuna protege a los individuos y las comunidades, al tiempo quereduce las posibilidades de que se produzcan brotes d...e enfermedades prevenibles mediante vacunación. La prevención de un brote de una enfermedad prevenible mediante vacunación no solo salva vidas, sino que requiere menos recursosque la respuesta al brote y ayuda a reducir la carga que supone para los sistemas de salud, los cuales ya están sometidos a una fuerte presión por la pandemia de COVID-19. En sus esfuerzos por mantener los sistemas de inmunización, los países deben adoptar enfoques que respeten el principio de «no hacer daño» y limiten la transmisión de la COVID-19 durante la realización de actividades de inmunización. Las visitas para la administración de vacunas también pueden ser una ocasión para divulgar mensajes que fomenten comportamientos que reducen el riesgo de transmisión del virus de la COVID-19 y para proporcionar orientaciones sobre las medidas que deben adoptarse si se observan síntomas.
more
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu...l to program managers starting to plan or scale-up provision of drugs and supplies for a HIV/AIDS program. Additionally, some of the information may be helpful to readers who are implementing a new program and may not have robust logistics systems in place. For other readers, this handbook may serve as a checklist of systems and procedures that need to be in place in order to manage the many of the health commodities required for the HIV/AIDS program.
more
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...ing this progress, countries have adopted the Every Newborn Tracking Tool. This report presents a compilation of the data collated by the Every Newborn Tracking Tool in 2016, when 51 countries adopted the tool; it also spotlights examples of specific country activity for each National Milestone. Finally, Global Milestones for 2020 were part of the Every Newborn Action Plan to guide global and regional work in support of country efforts and this report highlights relevant progress towards those Global Milestones.
more